Membranous nephropathy with systemic light-chain amyloidosis of remission after rituximab therapy: A case report

Table 2 Literature review of membranous nephropathy with amyloidosis

Ref.	No.	Patient	Country	Age	Sex	Proteinuria (g/d)	Scr (μmol/L)	ALB (g/L)
Kuroda et al[9], 2012	6		Japan	NA	NA	NA	NA	NA
Lu et al[10], 2017	1	Patient 1	China	64	M	10.06-10.52	77.35	26.7
Li et al[11], 2020	4	Patient 4	China	74	F	11.26	118	26.5
		Patient 5	China	61	F	2.44	76	22.3
		Patient 6	China	79	M	7.92	541.8	24.7
		Patient 7	China	61	F	3.89	70.2	31.4
Morel et al[12], 2022	1		France	56	M	UPCR 522 mg/mmol (after 6 years)	eGFR 78.9 mL/min/1.73 m2 (after 6 years)	23 (after 6 years)
Wang et al[13], 2022	1		China	39	M	8.01	95.3	13.1
The present case	1		China	48	M	17.84	97.3	18.3

ALB: Albumin; eGFR: Estimated glomerular filtration rate; F: Female; M: Male; No: Number; NA: Not available; SCr: Serum creatinine; UPCR: Urine protein/creatinine ratio.